How a little-known glycoprotein blocks a cancer cell’s immune response
Researchers uncovered how stanniocalcin-1, or STC1, works inside a tumor cell to block a cellular “eat-me” signal that typically triggers the immune system to produce T cells to fight the tumor. The findings provide a potential target to improve immune responses to cancer.
Read more